Does ROFLUMILAST Cause Neoplasm malignant? 17 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Neoplasm malignant have been filed in association with ROFLUMILAST (ROFLUMILAST). This represents 0.6% of all adverse event reports for ROFLUMILAST.
17
Reports of Neoplasm malignant with ROFLUMILAST
0.6%
of all ROFLUMILAST reports
4
Deaths
6
Hospitalizations
How Dangerous Is Neoplasm malignant From ROFLUMILAST?
Of the 17 reports, 4 (23.5%) resulted in death, 6 (35.3%) required hospitalization, and 1 (5.9%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROFLUMILAST. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does ROFLUMILAST Cause?
Death (569)
Dyspnoea (433)
Chronic obstructive pulmonary disease (292)
Diarrhoea (265)
Off label use (242)
Weight decreased (224)
Nausea (191)
Pneumonia (176)
Headache (166)
Malaise (164)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which ROFLUMILAST Alternatives Have Lower Neoplasm malignant Risk?
ROFLUMILAST vs ROLAPITANT
ROFLUMILAST vs ROMIDEPSIN
ROFLUMILAST vs ROMIPLOSTIM
ROFLUMILAST vs ROMOSOZUMAB
ROFLUMILAST vs ROMOSOZUMAB-AQQG